Diao et al.17found increased expression of TIM‐3 on CD4+ T cells in COVID‐19 patients admitted to the ICU. Consistent with their study, we found increased expression of TIM‐3 on CD4+ T cells in both moderate/severe and critical patients. The gene discussed is HAVCR2; the disease is COVID-19.